Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: The HIFMECH study

Metabolism: Clinical and Experimental

Volumn 53, Issue 7, 2004, Pages 852-857

  Yudkin, J S ^a   Juhan Vague, I ^b   Hawe, E ^b   Humphries, S E ^b   Di Minno, G ^b   Margaglione, M ^b   Tremoli, E ^b   Kooistra, T ^b   Morange, P E ^b   Lundman, P ^b   Mohamed Ali, V ^b   Hamsten, A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INSULIN; INTERLEUKIN 6; PROINSULIN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EUROPE; FACTORIAL ANALYSIS; GEOGRAPHY; HEART INFARCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 3042621265     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.02.004     Document Type: Article

References (35)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607
2. Mohamed-Ali V., Gould M.M., Gillies S., et al. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - Evidence against a modulating role for insulin. Diabetologia. 38:1995;1110-1116
3. Juhan-Vague I., Alessi M.C., Vague P. Increased plasma plasminogen activator inhibitor 1 levels A possible link between insulin resistance and atherothrombosis. Diabetologia. 34:1991;457-462
4. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., et al. C-reactive protein in healthy subjects Association with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 19:1999;972-978
5. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 137:1993;959-965
6. Hermans M.P., Levy J.C., Morris R.J., et al. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 42:1999;678-687
7. Hanson R.L., Pratley R.E., Bogardus C., et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 151:2000;190-198
8. Ruige J.B., Assendelft W.J., Dekker J.M., et al. Insulin and risk of cardiovascular disease A meta-analysis. Circulation. 97:1998;996-1001
9. Festa A., D'Agostino R. Jr, Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42-47
10. Juhan-Vague I., Thompson S.G., Jespersen J. The ECAT Angina Pectoris Study Group. Involvement of the hemostatic system in the insulin resistance syndrome A study of 1500 patients with angina pectoris. Arterioscler Thromb. 13:1993;1865-1873
11. Pinkney J., Coppack S.W., Yudkin J.S. Endothelial dysfunction Cause of the insulin resistance syndrome? Diabetes. 46:(suppl 2):1997;S9-S13
12. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue secretes interleukin-6 but not tumour necrosis factor-α in vivo. J Clin Endocrinol Metab. 82:1997;4196-4200
13. Yudkin J.S., Kumari M., Humphries S., et al. Inflammation, obesity, stress and coronary heart disease Is interleukin-6 the link? Atherosclerosis. 148:2000;209-214
14. Sakkinen P.A., Wahl P., Cushman M., et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol. 152:2000;897-907
15. Meigs J.B., D'Agostino R.B. Sr, Wilson P.W., et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 46:1997;1594-1600
16. Lempiäinen P., Mykkänen L., Pyörälä K., et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 100:1999;123-128
17. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288:2002;2709-2716
18. Pyörälä M., Miettinen H., Halonen P., et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 20:2000;538-544
19. Juhan-Vahue I., Morange P.E., Aubert H., et al. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol. 22:2002;867-873
20. de Maat M.P.M., Pijl H., Kluft C., et al. Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr. 54:2000;757-763
21. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
22. Yudkin J.S., Denver A.E., Mohamed-Ali V., et al. A study of two ethnic groups. The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. Diabetes Care. 20:1997;1093-1100
23. Yudkin J.S., May M., Elwood P., et al. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin Prospective data from the Caerphilly study. Diabetologia. 45:2002;327-336
24. Hatcher L. A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modelling. 1994;SAS Institute, Cary, NC
25. Hu F.B. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol. 153:2001;717-718
26. Meigs J.B. Invited commentary Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated risk factors. Am J Epidemiol. 152:2000;908-911
27. Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol. 280:2001;E745-E751
28. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose tissue expression of tumor-necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 95:1996;2409-2415
29. Kern P.A., Saghizadeh M., Ong J.M., et al. The expression of tumor necrosis factor in human adipose tissue Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 95:1995;2111-2119
30. Lindahl B., Dinesen B., Eliasson M., et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism. 48:1999;1197-1202
31. Miyao Y., Yasue H., Ogawa H., et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304
32. Pannitteri G., Marino B., Campa P.P., et al. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol. 80:1997;622-625
33. Meade T.W., Ruddock V., Stirling Y., et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 342:1993;1076-1079
34. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979
35. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767-1772